Bioceres Crop Solutions Corp. (NASDAQ:BIOX) Short Interest Update

Bioceres Crop Solutions Corp. (NASDAQ:BIOX) experienced a notable rise in short interest during December. As of December 31st, short interest reached a total of 717,500 shares, which represents an increase of 10.7% from the previous total of 648,400 shares reported on December 15th. This means that around 2.2% of the company's shares are currently sold short. Given the average daily trading volume of 193,500 shares, the days-to-cover ratio stands at 3.7 days.

Institutional Inflows and Outflows

Recently, several institutional investors have made adjustments to their holdings in Bioceres Crop Solutions. For instance, Dimensional Fund Advisors LP increased its stake by 9.5% in the second quarter, acquiring an additional 5,341 shares, bringing their total to 61,330 shares valued at approximately $688,000. Similarly, Stifel Financial Corp raised its position by 33.4% during the third quarter, now holding 40,790 shares worth $321,000 after purchasing 10,224 shares in the last quarter.

Moreover, JPMorgan Chase & Co. enhanced its stake by 49.3% in the third quarter, owning 89,973 shares valued at $708,000 following the acquisition of 29,693 shares. Long Focus Capital Management LLC also increased its investment by 19.9% in the second quarter, now possessing 280,547 shares valued at $3,145,000 after adding 46,647 shares. Finally, Fourth Sail Capital LP grew its stake significantly by 61.6% during the third quarter, totaling 3,171,102 shares valued at $24,957,000 after purchasing 1,209,277 shares. Currently, 17.68% of Bioceres Crop Solutions' stock is held by institutional investors.

Wall Street Analyst Opinions

Several brokerages have released reports concerning Bioceres Crop Solutions. Oppenheimer reduced their price target from $16.00 to $13.00 while maintaining an "outperform" rating for the stock in a report on October 21st. Similarly, Canaccord Genuity Group lowered their target price from $10.00 to $9.50, giving a "buy" rating in their research note dated November 13th. Overall, four analysts have rated the stock as a buy and two have given a strong buy rating. According to MarketBeat.com, the average rating for BIOX is "Buy" with an average price target of $12.13.

Bioceres Crop Solutions Stock Performance

On the trading day preceding this report, BIOX experienced a slight decline of 0.3%, dropping $0.02 to close at $6.89. The trading volume for the day was 123,341 shares, compared to its average of 134,753. The stock's fifty-day simple moving average stands at $6.58, while the 200-day simple moving average is $8.28. Bioceres Crop Solutions has a market capitalization of $433.04 million, a P/E ratio of 344.67, and a beta of 0.56. The stock has reached a 52-week low of $5.71 and a high of $14.05.

On November 11th, Bioceres Crop Solutions published its quarterly earnings report, revealing an earnings per share deficit of ($0.09), which fell short of the consensus estimate of $0.02 by ($0.11). The revenue recorded for the quarter was $92.60 million, compared to the anticipated $117.15 million. The company reported a net margin of 0.53% and a return on equity of 0.68%. In the previous year’s same quarter, the earnings per share were ($0.07). Analysts forecast that Bioceres Crop Solutions will post an EPS of $0.12 for the current fiscal year.

Bioceres Crop Solutions Company Overview

Bioceres Crop Solutions Corp. provides a range of crop productivity solutions through its subsidiaries. The business is segmented into Seed and Integrated Products, Crop Protection, and Crop Nutrition. The Seed and Integrated Products segment offers seed traits, germplasms, and seed treatment products aimed at enhancing crop health and yield.

Future Investment Considerations

Potential investors in Bioceres Crop Solutions may want to consider various opinions from market analysts before making decisions. While the company currently holds a "Buy" rating, notable analysts have identified five other stocks that may present better investment opportunities at this time.

Bioceres, Stocks, Investing